1. Home
  2. CSTL vs ALNT Comparison

CSTL vs ALNT Comparison

Compare CSTL & ALNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSTL
  • ALNT
  • Stock Information
  • Founded
  • CSTL 2007
  • ALNT 1962
  • Country
  • CSTL United States
  • ALNT United States
  • Employees
  • CSTL N/A
  • ALNT N/A
  • Industry
  • CSTL Medical Specialities
  • ALNT Electrical Products
  • Sector
  • CSTL Health Care
  • ALNT Industrials
  • Exchange
  • CSTL Nasdaq
  • ALNT Nasdaq
  • Market Cap
  • CSTL 697.9M
  • ALNT 791.9M
  • IPO Year
  • CSTL 2019
  • ALNT N/A
  • Fundamental
  • Price
  • CSTL $21.62
  • ALNT $46.65
  • Analyst Decision
  • CSTL Strong Buy
  • ALNT Buy
  • Analyst Count
  • CSTL 6
  • ALNT 1
  • Target Price
  • CSTL $37.67
  • ALNT $35.00
  • AVG Volume (30 Days)
  • CSTL 423.4K
  • ALNT 152.0K
  • Earning Date
  • CSTL 11-03-2025
  • ALNT 11-05-2025
  • Dividend Yield
  • CSTL N/A
  • ALNT 0.26%
  • EPS Growth
  • CSTL N/A
  • ALNT N/A
  • EPS
  • CSTL N/A
  • ALNT 0.85
  • Revenue
  • CSTL $346,269,000.00
  • ALNT $519,604,000.00
  • Revenue This Year
  • CSTL N/A
  • ALNT $3.38
  • Revenue Next Year
  • CSTL N/A
  • ALNT $3.97
  • P/E Ratio
  • CSTL N/A
  • ALNT $54.85
  • Revenue Growth
  • CSTL 20.40
  • ALNT N/A
  • 52 Week Low
  • CSTL $14.59
  • ALNT $16.91
  • 52 Week High
  • CSTL $35.84
  • ALNT $48.22
  • Technical
  • Relative Strength Index (RSI)
  • CSTL 50.19
  • ALNT 59.38
  • Support Level
  • CSTL $22.54
  • ALNT $43.82
  • Resistance Level
  • CSTL $24.74
  • ALNT $47.02
  • Average True Range (ATR)
  • CSTL 1.14
  • ALNT 1.53
  • MACD
  • CSTL -0.28
  • ALNT -0.19
  • Stochastic Oscillator
  • CSTL 28.93
  • ALNT 67.31

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

About ALNT Allient Inc.

Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty motion control components and systems. The firm primarily caters to the vehicle, medical, aerospace and defense, and electronics and industrial, pumps, and robotics sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.

Share on Social Networks: